French Brand DermEden Enters Korea's Medical Aesthetic Market — KOLs Weigh In on Indications and Positioning
Held at Lieul Dermatology Clinic in Seoul on May 26, the DermEden Pre-Launch Expert Session gathered Korean key opinion leaders in pigmentation care. Ahead of French dermocosmetic brand DermEden's Korean debut, local partner Primoris International shared early field-test results and examined where the line might fit in Korea's pigmentation market. The session ranged across the mechanism — how tranexamic acid (TXA) suppresses the plasmin pathway to act on pigment formation, melanosome transfer and PIH; the 5% TXA–niacinamide formulation; clinical cases in which Dr. Eunyoung Kang and Dr. Kyungtae Bae combined the line with lasers and exosome boosters; and a KOL panel discussion on indication selection and positioning. Notably, presenters and panelists converged on using DermEden alongside procedures such as lasers, exosome boosters and microneedling while narrowing its indications and patient groups: non-sensitive patients with non-severe melasma; post-procedure PIH prevention; and home-care continuity for international patients.
#MedicalAestheticNews #DermEden #PrimorisInternational #DrEunyoungKang #EYClinic #DrKyungtaeBae #ItsMeClinicSejong #DrHeewonSuh #CheongdamCircleClinic #DrHyoseungJang #PieobomClinicGangnam #DrKyounghunYoo #LumiClinic
★ Article Link: https://www.medicalaestheticnews.com/news/articleView.html?idxno=20068








Comments
Post a Comment